Stacey M Fernandes

Stacey M Fernandes

UNVERIFIED PROFILE

Are you Stacey M Fernandes?   Register this Author

Register author
Stacey M Fernandes

Stacey M Fernandes

Publications by authors named "Stacey M Fernandes"

Are you Stacey M Fernandes?   Register this Author

23Publications

778Reads

47Profile Views

Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies.

Authors:
Romain Guièze Vivian M Liu Daniel Rosebrock Alexis A Jourdain María Hernández-Sánchez Aina Martinez Zurita Jing Sun Elisa Ten Hacken Kaitlyn Baranowski Philip A Thompson Jin-Mi Heo Zachary Cartun Ozan Aygün J Bryan Iorgulescu Wandi Zhang Giulia Notarangelo Dimitri Livitz Shuqiang Li Matthew S Davids Anat Biran Stacey M Fernandes Jennifer R Brown Ana Lako Zoe B Ciantra Matthew A Lawlor Derin B Keskin Namrata D Udeshi William G Wierda Kenneth J Livak Anthony G Letai Donna Neuberg J Wade Harper Steven A Carr Federica Piccioni Christopher J Ott Ignaty Leshchiner Cory M Johannessen John Doench Vamsi K Mootha Gad Getz Catherine J Wu

Cancer Cell 2019 Oct 19;36(4):369-384.e13. Epub 2019 Sep 19.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Dana Building, Room DA-520, Boston MA 02215-02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ccell.2019.08.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801112PMC
October 2019

Growth dynamics in naturally progressing chronic lymphocytic leukaemia.

Authors:
Michaela Gruber Ivana Bozic Ignaty Leshchiner Dimitri Livitz Kristen Stevenson Laura Rassenti Daniel Rosebrock Amaro Taylor-Weiner Oriol Olive Reaha Goyetche Stacey M Fernandes Jing Sun Chip Stewart Alicia Wong Carrie Cibulskis Wandi Zhang Johannes G Reiter Jeffrey M Gerold John G Gribben Kanti R Rai Michael J Keating Jennifer R Brown Donna Neuberg Thomas J Kipps Martin A Nowak Gad Getz Catherine J Wu

Nature 2019 Jun 29;570(7762):474-479. Epub 2019 May 29.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/s41586-019-1252-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630176PMC
June 2019

Ofatumumab plus high dose methylprednisolone followed by ofatumumab plus alemtuzumab to achieve maximal cytoreduction prior to allogeneic transplantation for 17p deleted or TP53 mutated chronic lymphocytic leukemia.

Authors:
Matthew S Davids Haesook T Kim Lijian Yu Guadalupe De Maeyer Mikaela McDonough Alexander R Vartanov Rachael Langey Stacey M Fernandes Jeffrey M Hellman Karen Francoeur Jon Arnason Eric D Jacobsen Ann S LaCasce David C Fisher Jennifer R Brown

Leuk Lymphoma 2019 May 15;60(5):1312-1315. Epub 2018 Oct 15.

a Departments of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1080/10428194.2018.1519814DOI Listing
May 2019

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia.

Authors:
Benjamin L Lampson Haesook T Kim Matthew S Davids Jeremy S Abramson Arnold S Freedman Caron A Jacobson Philippe A Armand Robin M Joyce Jon E Arnason Laura Z Rassenti Thomas J Kipps Joshua Fein Stacey M Fernandes John R Hanna David C Fisher Jennifer R Brown

Blood Adv 2019 Apr;3(7):1167-1174

Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/bloodadvances.2018030221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457234PMC
April 2019

MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL.

Authors:
Ma Reina Improgo Bethany Tesar Josephine L Klitgaard Reuma Magori-Cohen Lijian Yu Siddha Kasar Divya Chaudhary Wenyan Miao Stacey M Fernandes Kevin Hoang William F Westlin Haesook T Kim Jennifer R Brown

Br J Haematol 2019 Mar 9;184(6):925-936. Epub 2018 Dec 9.

Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.15714DOI Listing
March 2019

Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.

Authors:
Christopher J Ott Alexander J Federation Logan S Schwartz Siddha Kasar Josephine L Klitgaard Romina Lenci Qiyuan Li Matthew Lawlor Stacey M Fernandes Amanda Souza Donald Polaski Deepti Gadi Matthew L Freedman Jennifer R Brown James E Bradner

Cancer Cell 2018 12 29;34(6):982-995.e7. Epub 2018 Nov 29.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT & Harvard, Cambridge, MA 02142, USA; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA. Electronic address:

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183048
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.11.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298230PMC
December 2018

Minimal residual disease detected by immunoglobulin sequencing predicts CLL relapse more effectively than flow cytometry.

Authors:
Andrew Aw Haesook T Kim Stacey M Fernandes Kevin Hoang Siddha Kasar Malek Faham Jennifer R Brown

Leuk Lymphoma 2018 08 22;59(8):1986-1989. Epub 2017 Nov 22.

e CLL Center and Department of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1080/10428194.2017.1397664DOI Listing
August 2018

Enhanced activation and expansion of T cells using mechanically soft elastomer fibers.

Authors:
Alex Dang Sarah De Leo Danielle R Bogdanowicz Dennis J Yuan Stacey M Fernandes Jennifer R Brown Helen H Lu Lance C Kam

Adv Biosyst 2018 Feb 18;2(2). Epub 2018 Jan 18.

Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA,

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/adbi.201700167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469863PMC
February 2018

Analysis of rare germ line variants in chronic lymphocytic leukemia.

Authors:
Grace Tiao M Reina Improgo Eugen Tausch Stacey M Fernandes Jasmin Bahlo Sandra Robrecht Kirsten Fischer Michael Hallek Stephan Stilgenbauer Adam Kiezun Gad Getz Jennifer R Brown

Blood 2017 11 19;130(22):2443-2444. Epub 2017 Oct 19.

Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood-2017-08-800128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709789PMC
November 2017

Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies.

Authors:
Xiaochuan Liu Aoli Wang Xiaofei Liang Juanjuan Liu Fengming Zou Cheng Chen Zheng Zhao Yuanxin Deng Hong Wu Ziping Qi Beilei Wang Li Wang Feiyang Liu Yunhe Xu Wenchao Wang Stacey M Fernandes Richard M Stone Ilene A Galinsky Jennifer R Brown Teckpeng Loh James D Griffin Shanchun Zhang Ellen L Weisberg Xin Zhang Jing Liu Qingsong Liu

Oncotarget 2016 Aug;7(33):53515-53525

High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, 230031, Anhui, P. R. China.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.18632/oncotarget.10650DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288202PMC
August 2016

Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.

Authors:
Rachel Thijssen Johanna Ter Burg Brett Garrick Gregor G W van Bochove Jennifer R Brown Stacey M Fernandes María Solé Rodríguez Jean-Marie Michot Michael Hallek Barbara Eichhorst Hans Christian Reinhardt Johanna Bendell Ingrid A M Derks Roel J W van Kampen Kristen Hege Marie José Kersten Torsten Trowe Ellen H Filvaroff Eric Eldering Arnon P Kater

Blood 2016 07 27;128(4):574-83. Epub 2016 May 27.

Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Lymphoma and Myeloma Center Amsterdam, The Netherlands.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood-2016-02-700328DOI Listing
July 2016

Characterization of selective and potent PI3Kδ inhibitor (PI3KDIN- 015) for B-Cell malignances.

Authors:
Xiaochuan Liu Aoli Wang Xiaofei Liang Cheng Chen Juanjuan Liu Zheng Zhao Hong Wu Yuanxin Deng Li Wang Beilei Wang Jiaxin Wu Feiyang Liu Stacey M Fernandes Sophia Adamia Richard M Stone Ilene A Galinsky Jennifer R Brown James D Griffin Shanchun Zhang Teckpeng Loh Xin Zhang Wenchao Wang Ellen L Weisberg Jing Liu Qingsong Liu

Oncotarget 2016 May;7(22):32641-51

High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, P. R. China.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.18632/oncotarget.8702DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078040PMC
May 2016

Human C1-Inhibitor Suppresses Malaria Parasite Invasion and Cytoadhesion via Binding to Parasite Glycosylphosphatidylinositol and Host Cell Receptors.

Authors:
Pedro Mejia Monica Diez-Silva Faustin Kamena Fengxin Lu Stacey M Fernandes Peter H Seeberger Alvin E Davis James R Mitchell

J Infect Dis 2016 Jan 7;213(1):80-9. Epub 2015 Sep 7.

Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1093/infdis/jiv439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676549PMC
January 2016

Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.

Authors:
Dan A Landau Kendell Clement Michael J Ziller Patrick Boyle Jean Fan Hongcang Gu Kristen Stevenson Carrie Sougnez Lili Wang Shuqiang Li Dylan Kotliar Wandi Zhang Mahmoud Ghandi Levi Garraway Stacey M Fernandes Kenneth J Livak Stacey Gabriel Andreas Gnirke Eric S Lander Jennifer R Brown Donna Neuberg Peter V Kharchenko Nir Hacohen Gad Getz Alexander Meissner Catherine J Wu

Cancer Cell 2014 Dec;26(6):813-825

Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Division of Hematology/Oncology, Children's Hospital, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ccell.2014.10.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302418PMC
December 2014

A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.

Authors:
Jennifer R Brown Bradley Messmer Lillian Werner Matthew S Davids Evgeny Mikler Jeffrey G Supko David C Fisher Ann S LaCasce Philippe Armand Eric Jacobsen Virginia Dalton Bethany Tesar Stacey M Fernandes Sean McDonough Jerome Ritz Laura Rassenti Thomas J Kipps Donna Neuberg Arnold S Freedman

Haematologica 2013 Jun 3;98(6):964-70. Epub 2013 May 3.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3324/haematol.2013.086207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669454PMC
June 2013

The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.

Authors:
Fengxin Lu Stacey M Fernandes Alvin E Davis

Cardiovasc Pathol 2013 Jan-Feb;22(1):75-80. Epub 2012 Jun 16.

Immune Disease Institute, Harvard Medical School, 3 Blackfan Circle, Boston, MA 02115, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.carpath.2012.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449044PMC
May 2013

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

Authors:
Dan A Landau Scott L Carter Petar Stojanov Aaron McKenna Kristen Stevenson Michael S Lawrence Carrie Sougnez Chip Stewart Andrey Sivachenko Lili Wang Youzhong Wan Wandi Zhang Sachet A Shukla Alexander Vartanov Stacey M Fernandes Gordon Saksena Kristian Cibulskis Bethany Tesar Stacey Gabriel Nir Hacohen Matthew Meyerson Eric S Lander Donna Neuberg Jennifer R Brown Gad Getz Catherine J Wu

Cell 2013 Feb;152(4):714-26

Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.cell.2013.01.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575604PMC
February 2013

LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.

Authors:
Yong Zhang Aldo M Roccaro Christopher Rombaoa Ludmilla Flores Susanna Obad Stacey M Fernandes Antonio Sacco Yang Liu Hai Ngo Phong Quang Abdel Kareem Azab Feda Azab Patricia Maiso Michaela Reagan Jennifer R Brown To-Ha Thai Sakari Kauppinen Irene M Ghobrial

Blood 2012 Aug 13;120(8):1678-86. Epub 2012 Jul 13.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

 Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-02-41
Publisher Site
http://dx.doi.org/10.1182/blood-2012-02-410647DOI Listing
August 2012

Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia.

Authors:
Jennifer R Brown Megan Hanna Bethany Tesar Lillian Werner Nathalie Pochet John M Asara Yaoyu E Wang Paola Dal Cin Stacey M Fernandes Christina Thompson Laura Macconaill Catherine J Wu Yves Van de Peer Mick Correll Aviv Regev Donna Neuberg Arnold S Freedman

Clin Cancer Res 2012 Jul 23;18(14):3791-802. Epub 2012 May 23.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719990PMC
July 2012

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

Authors:
Lili Wang Michael S Lawrence Youzhong Wan Petar Stojanov Carrie Sougnez Kristen Stevenson Lillian Werner Andrey Sivachenko David S DeLuca Li Zhang Wandi Zhang Alexander R Vartanov Stacey M Fernandes Natalie R Goldstein Eric G Folco Kristian Cibulskis Bethany Tesar Quinlan L Sievers Erica Shefler Stacey Gabriel Nir Hacohen Robin Reed Matthew Meyerson Todd R Golub Eric S Lander Donna Neuberg Jennifer R Brown Gad Getz Catherine J Wu

N Engl J Med 2011 Dec 12;365(26):2497-506. Epub 2011 Dec 12.

Cancer Vaccine Center and the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

 Source
http://www.nejm.org/doi/abs/10.1056/NEJMoa1109016
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1109016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685413PMC
December 2011

The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.

Authors:
Fengxin Lu Stacey M Fernandes Alvin E Davis

Am J Physiol Gastrointest Liver Physiol 2010 Jun 25;298(6):G878-83. Epub 2010 Mar 25.

Immune Disease Institute, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

 Source
http://ajpgi.physiology.org/content/ajpgi/298/6/G878.full.pd
Web Search
http://ajpgi.physiology.org/cgi/doi/10.1152/ajpgi.00400.2009
Publisher Site
http://dx.doi.org/10.1152/ajpgi.00400.2009DOI Listing
June 2010

The effect of C1 inhibitor on intestinal ischemia and reperfusion injury.

Authors:
Fengxin Lu Anil K Chauhan Stacey M Fernandes Meghan T Walsh Denisa D Wagner Alvin E Davis

Am J Physiol Gastrointest Liver Physiol 2008 Nov 11;295(5):G1042-9. Epub 2008 Sep 11.

Immune Disease Inst., Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1152/ajpgi.90460.2008DOI Listing
November 2008

C1 inhibitor-mediated protection from sepsis.

Authors:
Dongxu Liu Fengxin Lu Gangjian Qin Stacey M Fernandes Jinan Li Alvin E Davis

J Immunol 2007 Sep;179(6):3966-72

CBR Institute for Biomedical Research, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.4049/jimmunol.179.6.3966DOI Listing
September 2007